| Bioactivity | SARS-CoV-2-IN-19 (Compound 6g) is a potent inhibitor of SARS-CoV-2 with an EC50 of 8.8 μM. SARS-CoV-2-IN-19 shows potent activity against SARS-CoV-2 helicase (nsp13), a highly conserved enzyme, highlighting a potentiality against emerging HCoVs outbreaks. SARS-CoV-2-IN-19 has the potential for the research of infection diseases[1]. |
| Name | SARS-CoV-2-IN-19 |
| CAS | 2244991-17-9 |
| Formula | C33H38N2O6 |
| Molar Mass | 558.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nizi MG, et al. Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity. ACS Med Chem Lett. 2022 May 3;13(5):855-864. |
SARS-CoV-2-IN-19
CAS: 2244991-17-9 F: C33H38N2O6 W: 558.66
SARS-CoV-2-IN-19 (Compound 6g) is a potent inhibitor of SARS-CoV-2 with an EC50 of 8.8 μM. SARS-CoV-2-IN-19 shows poten
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.